{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T01:17:04Z","timestamp":1788225424311,"version":"build-2803163510"},"reference-count":22,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>Introduction: Primary hyperoxaluria (PH) is a rare autosomal recessive disease characterized by an excess of oxalate, which results in nephrolithiasis, nephrocalcinosis, and ultimately, renal failure and systemic oxalosis. There are 3 forms of PH, named types 1, 2, and 3, caused by variants in the AGXT, GRHPR, and HOGA1 genes, respectively. In Morocco, where consanguinity is common, recurrent variants, mainly affecting the AGXT gene, have been documented; however, the overall molecular profile of PH remains poorly characterized. We aim here to describe the mutational landscape of PH in Morocco and to provide an accurate diagnostic approach. Methods: We analyzed 132 patients referred over 10 years for PH using a stepwise strategy. A step 1 test involved Sanger sequencing of exon 7 of the AGXT gene, followed by sequencing of exons 1, 2, and 10 of the AGXT gene. The step 2 analysis consists of a customized gene panel targeting the three PH-associated genes. Unresolved cases underwent whole-exome sequencing as a third step. Results: First-line Sanger sequencing identified biallelic pathogenic or likely pathogenic AGXT variants in 95 of 132 patients suspected of PH, corresponding to a diagnostic yield of 72%. Additional molecular diagnoses obtained through targeted PH panel sequencing and WES increased the final cumulative diagnostic yield to 78%. Twelve distinct variants were characterized by Sanger sequencing, with the c.731T&gt;C in exon 7 of the AGXT gene, emerging as the most prevalent variant, supporting its founder effect in this population. Other variants were predominantly located in exons 7, 10, 2, and 1, highlighting mutation hotspots in this population. In unresolved cases, next-generation sequencing (NGS), including targeted gene panels and exome sequencing, uncovered additional pathogenic variants in the AGXT gene and variants in other genes associated with PH-like phenotypes. Conclusions: These results highlight the need for a simplified, exon-focused diagnostic strategy, particularly in resource-limited settings like Morocco.<\/jats:p>","DOI":"10.3390\/genes17091056","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T01:05:26Z","timestamp":1788224726000},"page":"1056","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mutational Landscape of Primary Hyperoxaluria in Morocco: Update and Implications for Diagnosis"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-0484-8065","authenticated-orcid":false,"given":"Ourayna","family":"Batta","sequence":"first","affiliation":[{"name":"Research Team in Genomics and Molecular Epidemiology of Genetic Diseases, Genomics of Human Pathologies Center, Faculty of Medicine and Pharmacy of Rabat, University Mohammed V, Rabat 10100, Morocco"},{"name":"Department of Medical Genetics, National Institute of Health, Rabat 10090, Morocco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5110-5345","authenticated-orcid":false,"given":"Yasmina","family":"Rahmuni","sequence":"additional","affiliation":[{"name":"Research Team in Genomics and Molecular Epidemiology of Genetic Diseases, Genomics of Human Pathologies Center, Faculty of Medicine and Pharmacy of Rabat, University Mohammed V, Rabat 10100, Morocco"},{"name":"Department of Medical Genetics, National Institute of Health, Rabat 10090, Morocco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4796-1872","authenticated-orcid":false,"given":"Jaber","family":"Lyahyai","sequence":"additional","affiliation":[{"name":"Research Team in Genomics and Molecular Epidemiology of Genetic Diseases, Genomics of Human Pathologies Center, Faculty of Medicine and Pharmacy of Rabat, University Mohammed V, Rabat 10100, Morocco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zineb","family":"Rchiad","sequence":"additional","affiliation":[{"name":"Genomics Platform, Biosciences CoreLab, Mohammed VI Polytechnic University (UM6P), Ben Guerir 43150, Morocco"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"methodology","vocabulary":"credit"}]},{"given":"Yassamine","family":"Doubaj","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, National Institute of Health, Rabat 10090, Morocco"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"investigation","vocabulary":"credit"}]},{"given":"Abdelaziz","family":"Sefiani","sequence":"additional","affiliation":[{"name":"Research Team in Genomics and Molecular Epidemiology of Genetic Diseases, Genomics of Human Pathologies Center, Faculty of Medicine and Pharmacy of Rabat, University Mohammed V, Rabat 10100, Morocco"},{"name":"Department of Medical Genetics, National Institute of Health, Rabat 10090, Morocco"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"supervision","vocabulary":"credit"}]},{"given":"Imane Cherkaoui","family":"Jaouad","sequence":"additional","affiliation":[{"name":"Research Team in Genomics and Molecular Epidemiology of Genetic Diseases, Genomics of Human Pathologies Center, Faculty of Medicine and Pharmacy of Rabat, University Mohammed V, Rabat 10100, Morocco"},{"name":"Department of Medical Genetics, National Institute of Health, Rabat 10090, Morocco"},{"name":"Unity of Medical Genetics, Children\u2019s Hospital, Ibn Sina University Hospital Center, Faculty of Medicine and Pharmacy, Mohammed V University of Rabat, Rabat 10100, Morocco"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/s41581-022-00661-1","article-title":"Clinical practice recommendations for primary hyperoxaluria: An expert consensus statement from ERKNet and OxalEurope","volume":"19","author":"Groothoff","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1056\/NEJMra1301564","article-title":"Primary hyperoxaluria","volume":"369","author":"Cochat","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1089\/gtmb.2015.0136","article-title":"AGXT Gene Mutations and Prevalence of Primary Hyperoxaluria Type 1 in Moroccan Population","volume":"19","author":"Boualla","year":"2015","journal-title":"Genet. Test. Mol. Biomark."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1017\/S0021932009003393","article-title":"Consanguineous marriages in Morocco and the consequence for the incidence of autosomal recessive disorders","volume":"41","author":"Jaouad","year":"2009","journal-title":"J. Biosoc. Sci."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/j.1523-1755.2004.00842.x","article-title":"Evaluation of mutation screening as a first line test for the diagnosis of the primary hyperoxalurias","volume":"66","author":"Rumsby","year":"2004","journal-title":"Kidney Int."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/0888-7543(91)90481-S","article-title":"Characterization and chromosomal mapping of a genomic clone encoding human alanine: Glyoxylate aminotransferase","volume":"10","author":"Purdue","year":"1991","journal-title":"Genomics"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1517\/13543784.2013.741587","article-title":"Hyperoxaluria and systemic oxalosis: An update on current therapy and future directions","volume":"22","author":"Beck","year":"2013","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"i33","DOI":"10.1093\/ckj\/sfab203","article-title":"Primary hyperoxaluria type 1 in developing countries: Novel challenges in a new therapeutic era","volume":"15","author":"Soliman","year":"2022","journal-title":"Clin. Kidney J."},{"key":"ref_9","first-page":"634175","article-title":"Primary hyperoxaluria type 1 in 18 children: Genotyping and outcome","volume":"2015","year":"2015","journal-title":"Int. J. Nephrol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.gene.2013.06.023","article-title":"Mutation spectrum of primary hyperoxaluria type 1 in Tunisia: Implication for diagnosis in North Africa","volume":"527","author":"Nagara","year":"2013","journal-title":"Gene"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4103\/1319-2442.225202","article-title":"Mutational analysis of AGXT gene in Libyan children with primary hyperoxaluria type 1 at Tripoli Children Hospital","volume":"29","author":"Rhuma","year":"2018","journal-title":"Saudi J. Kidney Dis. Transplant."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1007\/s00467-022-05784-y","article-title":"Clinical and molecular characterization of a large primary hyperoxaluria cohort from Saudi Arabia: A retrospective study","volume":"38","author":"Alfadhel","year":"2023","journal-title":"Pediatr. Nephrol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s00438-022-01897-z","article-title":"Genetic testing enables a precision medicine approach for nephrolithiasis and nephrocalcinosis in pediatrics: A single-center cohort","volume":"297","author":"Huang","year":"2022","journal-title":"Mol. Genet. Genom."},{"key":"ref_14","unstructured":"Adam, M.P., Bick, S., Mirzaa, G.M., Pagon, R.A., Wallace, S.E., and Amemiya, A. (2026, May 08). Dent Disease, GeneReviews\u00ae, Available online: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK99494\/."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1016\/j.ekir.2021.08.033","article-title":"Comprehensive Genetic Analysis Reveals Complexity of Monogenic Urinary Stone Disease","volume":"6","author":"Cogal","year":"2021","journal-title":"Kidney Int. Rep."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1093\/ndt\/gfab171","article-title":"Distal renal tubular acidosis: ERKNet\/ESPN clinical practice points","volume":"36","author":"Trepiccione","year":"2021","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Belmont, J.W., Reid, B., Taylor, W., Baker, S.S., Moore, W.H., Morriss, M.C., Podrebarac, S.M., Glass, N., and Schwartz, I.D. (2002). Congenital sucrase-isomaltase deficiency presenting with failure to thrive, hypercalcemia, and nephrocalcinosis. BMC Pediatr., 2.","DOI":"10.1186\/1471-2431-2-4"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/humu.9392","article-title":"Novel mutations in the human sucrase-isomaltase gene (SI) that cause congenital carbohydrate malabsorption","volume":"27","author":"Sander","year":"2006","journal-title":"Hum. Mutat."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Goel, M., Suthar, R., and Dawman, L. (2025). Congenital Glucose\u2013Galactose Malabsorption Presenting as Hypertriglyceridemia and Medullary Nephrocalcinosis. Pediatr. Rep., 17.","DOI":"10.3390\/pediatric17050090"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1093\/ndt\/gfs078","article-title":"Primary hyperoxaluria Type 1: Indications for screening and guidance for diagnosis and treatment","volume":"27","author":"Cochat","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1681\/ASN.2014070698","article-title":"Rare Kidney Stone Consortium. Phenotype-Genotype Correlations and Estimated Carrier Frequencies of Primary Hyperoxaluria","volume":"26","author":"Hopp","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1159\/000539516","article-title":"Mutation Characteristics of Primary Hyperoxaluria in the Chinese Population and Current International Diagnosis and Treatment Status","volume":"10","author":"Zhu","year":"2024","journal-title":"Kidney Dis."}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/17\/9\/1056\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T01:11:35Z","timestamp":1788225095000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/17\/9\/1056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,31]]},"references-count":22,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["genes17091056"],"URL":"https:\/\/doi.org\/10.3390\/genes17091056","relation":{},"ISSN":["2073-4425"],"issn-type":[{"value":"2073-4425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,31]]}}}